MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05810cam a22002774a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20231011162524.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
060501s2007 moua b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1416025529 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781416025528 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
BUL |
| Transcribing agency |
BUL |
| Modifying agency |
BUL |
| Language of cataloging |
eng |
| Description conventions |
rda |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 4 L523p 2007 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lehne, Richard A., |
| Dates associated with a name |
1943- |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Pharmacology for nursing care / |
| Statement of responsibility, etc. |
Richard A. Lehne, in consultation with Linda A. Moore, Leanna J. Crosby, Diane B. Hamilton. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
6th edition |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
St. Louis, Mo. : |
| Name of publisher, distributor, etc. |
Saunders Elsevier, |
| Date of publication, distribution, etc. |
c2007. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xxii, 1354 p. : |
| Other physical details |
col. ill. ; |
| Dimensions |
29 cm. + |
| Accompanying material |
1 CD-ROM (4 3/4 in.) |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Contents<br/><br/>I. Introduction<br/>1. Orientation of pharmacology <br/>2. Application of pharmacology in nursing practice <br/>3. Drug regulation, development, names, and information<br/><br/>II. Basic principles of pharmacology<br/>4. Pharmacokinetics <br/>5. Pharmacodynamics<br/>6. Drug interactions <br/>7. Adverse drug reactions and medication errors <br/>8. Individual variation in drug responses <br/><br/>III. Drug therapy across the life span<br/>9. Drug therapy during pregnancy and breast-feeding <br/>10. Drug therapy in pediatric patients <br/>11. Drug therapy in geriatric patients <br/><br/>IV. Peripheral nervous system drugs<br/>12. Basic principles of neuropharmacology <br/>13. Physiology of the peripheral nervous system <br/>14. Muscarinic agonists and antagonists <br/>15. Cholinesterase inhibitors and their use in myasthenia gravis <br/>16. Drugs that block nicotinic cholinergic transmission : neuromuscular blocking agents and ganglionic blocking agents <br/>17. Adrenergic agonists <br/>18. Adrenergic antagonists<br/>19. Indirect-acting antiadrenergic agents <br/><br/>V. Central Nervous system drugs<br/>VI. Drugs that affect fluid and electrolyte Balance<br/>40. Diuretics<br/>41, Agents affecting the volume and ion content of body fluids<br/><br/>VII. Drugs that affect the heart, blood vessels and blood<br/>42. Review of hemodynamics<br/>43. Drugs acting on the renin-angiotensin-aldosterone system --<br/>44. Calcium channel blockers<br/>45. Vasodilators <br/>46. Drugs for hypertension <br/>47. Drugs for heart failure<br/>48. Antidysrhythmic drugs <br/>49. Prophylaxis of coronary heart disease : drugs that lower LDL cholesterol levels <br/>50. Drugs for angina pectoris <br/>51. Anticoagulant, antiplatelet, and thrombolytic drugs <br/>52. Management of ST-elevation myocardial infarction <br/>53. Drugs for hemophilia <br/>54. Drugs for deficiency anemias <br/>55. Hematopoietic growth factors <br/><br/>VIII. Drugs for endocrine disorders<br/>56. Drugs for diabetes mellitus <br/>57. Drugs for thyroid disorders<br/>58. Drugs related to hypothalamic and pituitary function <br/>59. Drugs for disorders of the adrenal cortex <br/><br/>IX. Women's health<br/>60. Estrogens and progestins : basic pharmacology and noncontraceptive applications --<br/>61. Birth control --<br/>62. Drug therapy of infertility --<br/>63. Drugs that affect uterine function <br/><br/>X. Men's health<br/>64. Androgens <br/>65. Drugs for erectile dysfunction and benign prostatic hyperplasia <br/><br/>XI. Anti-inflammatory, antiallergic,and immunologic dugs<br/>66. Review of the immune system<br/>67. Childhood immunization <br/>68. Immunosuppressants<br/>69. Antihistamines <br/>70. Cyclooxygenase inhibitors : nonsteroidal anti-inflammatory drugs and acetaminophen <br/>71. Glucocorticoids in nonendocrine diseases <br/><br/>XII. Drugs for bone and joint disorders<br/>72. Drug therapy of rheumatoid arthritis and gout <br/>73. Drugs affecting calcium levels and bone mineralization <br/><br/>XIII. Respiratory Tract drugs<br/>74. Drugs for asthma <br/>75. Drugs for allergic rhinitis, cough, and colds<br/><br/>XIV. Gastrointestinal drugs<br/>76. Drugs for peptic ulcer disease <br/>77. Laxatives<br/>78. Other gastrointestinal drugs <br/><br/>XV. Nutrition<br/>79. Vitamins<br/>80. Enteral and parenteral nutrition <br/>81. Drugs for obesity <br/>82. Basic principles of antimicrobial therapy <br/>83. Drugs that weaken the bacterial cell wall I : penicillins <br/>84. Drugs that weaken the bacteria cell wall II : cephalosporins, carbapenems, vancomycin, aztreonam, teicoplanin, and fosfomycin 85. Bacteriostatic inhibitors of protein synthesis : tetracyclines, macrolides, and others <br/>86. Aminoglycosides : bactericidal inhibitors of protein synthesis<br/>87. Sulfonamides and trimethoprim <br/>88. Drug therapy of urinary tract infections<br/>89. Antimycobacterial agents : drugs for tuberculosis, leprosy, and Mycobacterium avium complex infection --<br/>90. Miscellaneous antibacterial drugs : fluoroquinolones, metronidazole, daptomycin, rifampin, bacitracin, and polymyxins <br/>91. Antifungal agents <br/>92. Antiviral agents I : drugs for non-HIV viral infections<br/>93. Antiviral agents II : drugs for HIV infection and related opportunistic infections <br/>94. Drug therapy of sexually transmitted diseases <br/>95. Antiseptics and disinfectants<br/><br/>XVII: Chemotherapy of parasitic diseases<br/>96. Anthelmintics <br/>97. Antiprotozoal drugs I : antimalarial agents <br/>98. Antiprotozoal drugs II : miscellaneous agents <br/>99. Ectoparasiticides <br/><br/>XVIII. Cancer chemotherapy<br/>100. Basic principles of cancer chemotherapy <br/>101. Anticancer drugs I : cytotoxic agents <br/>102. Anticancer drugs II : hormonal agents, biologic response modifiers, and targeted drugs <br/><br/>XIX. Additional important drugs<br/>103. Drugs for the eye <br/>104. Drugs for the skin <br/>105. Drugs for the ear <br/>106. Miscellaneous noteworthy drugs <br/><br/>XX. Alternative therapy<br/>107. Herbal supplements <br/><br/>XXI Toxicology<br/>108. Management of poisoning <br/>109. Potential weapons of biologic, radiologic, and chemical terrorism |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Nursing. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drug Therapy |
| Form subdivision |
Nurses' Instruction. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology |
| Form subdivision |
Nurses' Instruction. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Book Open Access |
| Edition |
6th edition |
| Classification part |
QV 4 L523p 2007 |
| Item part |
1 |
| Call number prefix |
QV 4 |
| Call number suffix |
L523p 2007 |
